Evaluation of abnormal liver-enzyme results in asymptomatic patients

New England Journal of Medicine

Volumn 342, Issue 17, 2000, Pages 1266-1271

  Pratt, Daniel S ^a   Kaplan, Marshall M ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; ALPHA 1 ANTITRYPSIN; AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; GAMMA GLUTAMYLTRANSFERASE; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ALCOHOL ABUSE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOIMMUNE HEPATITIS; ENZYME ANALYSIS; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FUNCTION TEST; LIVER LEVEL; LIVER TOXICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STEATOSIS; WILSON DISEASE;

ALKALINE PHOSPHATASE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; TRANSAMINASES;

EID: 0034720287     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200004273421707     Document Type: Article

References (30)

1. Pratt DS, Kaplan MM. Laboratory tests. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. 8th ed. Vol. 1. Philadelphia: Lippincott-Raven, 1999:205-44.
2. Piton A, Poynard T, Imbert-Bismut F, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology 1998;27:1213-9.
3. Kundrotas LW, Clement DJ. Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors. Dig Dis Sci 1993;38:2145-50.
4. Katkov WN, Friedman LS, Cody H, et al. Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus. Ann Intern Med 1991;115:882-4.
5. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroencerol 1986;21:109-13.
6. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94:3010-4.
7. Cohen JA, Kaplan MM. The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Dig Dis Sci 1979;24:835-8.
8. Diehl AM, Potter J, Boitnott J, Van Duyn MA, Herlong HF, Mezey E. Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86:632-6.
9. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
10. Schiff ER, de Medina M, Kahn RS. New perspectives in the diagnosis of hepatitis C. Semin Liver Dis 1999;19:Suppl 1:3-15.
11. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996;334:897-903.
12. Manns MP. Autoimmune hepatitis. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. 8th ed. Vol. 2. Philadelphia: Lippincott-Raven, 1999:919-35.
13. Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984;4:1-12.
14. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-62.
15. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: in expanded clinical entity. Gastroenterology 1994;107:1103-9.
16. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999; 94:1018-22.
17. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
18. Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986;220:83-8.
19. Hasegawa T, Yoneda M, Nakamura K, et al. Diagnostic significance of measurement of serum transforming growth factor β1 (TGF-β1) level and effect of α-tocopherol in patients with nonalcoholic steatohepatitis (NASH). Gastroenterology 1997;112:Suppl 1:A1278. abstract.
20. Lavine JE. Treatment of obesity-induced steatohepatitis with vitamin E. Gastroenterology 1998;114:A1284. abstract.
21. Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996;23:1464-7.
22. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998;129:925-31.
23. Bardella MT, Vecchi M, Conte D, et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 1999; 29:654-7.
24. Das A, Post AB. Should liver biopsy be done in asymptomatic patients with chronically elevated transaminases: a cost-utility analysis. Gastroenterology 1998;114:A9. abstract.
25. Sorbi D, McGill DB, Thistle JL, Henry JJ, Therneau TM, Lindor KD. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Hepatology 1999;30:Suppl:477A. abstract.
26. Wolf PL. Clinical significance of an increased or decreased serum alkaline phosphatase level. Arch Pathol Lab Med 1978;102:497-501.
27. Goldberg DM, Martin JV. Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease. Digestion 1975;12:232-46.
28. Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet 1971;2:376-7.
29. Moussavian SN, Becker RC, Piepmeyer JL, Mezey E, Bozian RC. Serum gamma-glutamyl transpeptidase and chronic alcoholism: influence of alcohol ingestion and liver disease. Dig Dis Sci 1985;30:211-4.
30. Orrego H, Blake JE, Israel Y. Relationship between gamma-glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol withdrawal. Alcohol Clin Exp Res 1985;9:10-3.